USD 2.19
(6.31%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 11.07 Million USD | -28.38% |
2022 | 15.46 Million USD | 89.72% |
2021 | 8.15 Million USD | 87.87% |
2020 | 4.33 Million USD | -34.78% |
2019 | 6.65 Million USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 11.79 Million USD | -2.62% |
2024 Q1 | 12.11 Million USD | 9.41% |
2023 FY | 11.07 Million USD | -28.38% |
2023 Q3 | 11.44 Million USD | -13.06% |
2023 Q2 | 13.16 Million USD | -17.58% |
2023 Q1 | 15.96 Million USD | 3.28% |
2023 Q4 | 11.07 Million USD | -3.22% |
2022 Q3 | 15.18 Million USD | 20.01% |
2022 Q2 | 12.65 Million USD | 24.86% |
2022 Q1 | 10.13 Million USD | 24.34% |
2022 FY | 15.46 Million USD | 89.72% |
2022 Q4 | 15.46 Million USD | 1.82% |
2021 Q4 | 8.15 Million USD | 12.63% |
2021 FY | 8.15 Million USD | 87.87% |
2021 Q3 | 7.23 Million USD | 24.16% |
2021 Q2 | 5.82 Million USD | 0.0% |
2021 Q1 | - USD | -100.0% |
2020 Q1 | - USD | 0.0% |
2020 FY | 4.33 Million USD | -34.78% |
2020 Q4 | 4.33 Million USD | 0.0% |
2019 FY | 6.65 Million USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Abbott Laboratories | 6.57 Billion USD | 99.831% |
Allurion Technologies Inc. | 6.17 Million USD | -79.452% |
Artivion, Inc. | 81.97 Million USD | 86.491% |
Avanos Medical, Inc. | 163.2 Million USD | 93.214% |
Butterfly Network, Inc. | 75.83 Million USD | 85.398% |
Butterfly Network, Inc. | 75.83 Million USD | 85.398% |
Bio-Rad Laboratories, Inc. | 780.51 Million USD | 98.581% |
Boston Scientific Corporation | 2.48 Billion USD | 99.554% |
Perspective Therapeutics, Inc. | 1.4 Million USD | -685.947% |
CONMED Corporation | 318.32 Million USD | 96.521% |
Edwards Lifesciences Corporation | 1.16 Billion USD | 99.052% |
Paragon 28, Inc. | 98.06 Million USD | 88.707% |
Glaukos Corporation | 41.98 Million USD | 73.625% |
Globus Medical, Inc. | 848.13 Million USD | 98.694% |
Inspire Medical Systems, Inc. | 33.88 Million USD | 67.319% |
Integer Holdings Corporation | 239.71 Million USD | 95.38% |
Medtronic plc | 5.21 Billion USD | 99.788% |
Nevro Corp. | 118.67 Million USD | 90.669% |
Owlet, Inc. | 6.49 Million USD | -70.553% |
Penumbra, Inc. | 388.02 Million USD | 97.146% |
Vicarious Surgical Inc. | - USD | -Infinity% |
Smith & Nephew plc | 2.39 Billion USD | 99.538% |
STERIS plc | 674.53 Million USD | 98.358% |
Stryker Corporation | 4.84 Billion USD | 99.771% |
Vapotherm, Inc. | 22.96 Million USD | 51.785% |
Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 99.536% |